Columbia Sportswear

COLM · NASDAQ

$61.10+$1.12 (+1.87%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $59.98

COLM analyst rating

HoldConsensus of 4 analysts over the last 12 months. 50% rate it a buy.

Strong buy0
Buy2
Hold1
Underperform0
Sell1

12-month price target · 10 analysts

Average $70.86 (+16.0% upside)

Low: $47.47
Now: $61.10
High: $96.60

Upgrades and downgrades

The latest rating actions, newest first

COLM analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
Stifel	Jul 31, 2026	Maintains	Buy	$70.00 → $67.00	30%
BTIG	Jul 31, 2026	Maintains	Buy	$80.00	55%
Citigroup	Jul 22, 2026	Maintains	Neutral	$67.00 → $68.00	53%
Citigroup	May 4, 2026	Maintains	Neutral	$65.00 → $67.00	53%
UBS	May 1, 2026	Maintains	Sell	$44.00 → $47.00	51%
BTIG	May 1, 2026	Maintains	Buy	$75.00 → $80.00	55%
BTIG	Apr 24, 2026	Maintains	Buy	$75.00	55%
Citigroup	Feb 4, 2026	Maintains	Neutral	$55.00 → $62.00	53%
UBS	Feb 4, 2026	Maintains	Sell	$39.00 → $44.00	51%
BTIG	Feb 4, 2026	Maintains	Buy	$75.00	55%

The case for and against

Updated Oct 14, 2026

Bull case

Columbia Sportswear is positioned for a constructive turnaround because 1Q26 showed resilient fundamentals, with revenue of $779 million, adjusted EPS of $0.65, and operating margin of 5.4% all beating expectations despite tariff pressure. Its gross margin held up at 50.7% as pricing actions and other mitigation efforts offset a roughly 310 bps tariff headwind, while inventory stayed flat at $624 million and the company ended with $535 million in cash and no debt, underscoring financial flexibility. The outlook is further supported by improving Fall ’26 order trends, stronger product momentum from Amaze and ROC lines, growth across all four brands and international markets, and a shareholder-friendly capital allocation approach that included over $200 million of buybacks and about $66 million in dividends in 2025.

Bear case

Columbia Sportswear is facing a negative outlook because core brand performance remains under pressure, with Columbia brand sales down 2% CC, SOREL down 14% CC, and prAna down 5% CC, suggesting the turnaround in its flagship and specialty labels is not yet broad-based. Weakness is still concentrated in the U.S., where sales fell 10% CC as intentional inventory reductions and a lighter Spring order book weighed on wholesale and DTC channels, which declined 3% CC and 2% CC, respectively. Although EMEA rose 21% CC and LAAP and Canada grew modestly, management’s warnings about higher consumer prices hurting demand, plus tariff and trade uncertainty, reinforce downside risk if the brand refresh fails to deliver.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.